Granulomas in Pediatric Liver Biopsies: Single Center Experience

Muhammad Shaheen,Guang-Sheng Lei,Ryan F. Relich,Chaowapong Jarasvaraparn,Kyla M. Tolliver,Jean P. Molleston,Iván A. González
DOI: https://doi.org/10.1177/10935266231221908
2024-01-16
Pediatric and Developmental Pathology
Abstract:Pediatric and Developmental Pathology, Ahead of Print. Background:Granulomas in pediatric liver biopsies (GPLB) are rare with the largest pediatric cohort reported over 25 years ago.Methods:Single-center retrospective study of GPLB.Results:Seventeen liver biopsies from 16 patients with granulomas were identified (9 boys, 56%) with a median age of 13 years (range: 1–18) for which the most common indication was the presence of a nodule/mass (47%). Significant comorbidities were seen in 13 patients (81%) and included: liver transplant (25%), history of a neoplasm (25%), autoimmune hepatitis (6%), Crohn disease (6%), bipolar disorder (6%), severe combined immunodeficiency (6%), and sickle cell disease (6%). Eleven patients were taking multiple medications at the time of biopsy. Granulomas were more commonly pan-acinar (11 cases) followed by subcapsular (4 cases), portal (1 case), and periportal (1 case). Necrosis was seen in 10 cases (59%). GMS stain was positive in 2 cases for Histoplasma-like yeast; microbiological cultures were negative in all cases (no: 4). A 18S and 16S rRNA gene sequencing performed in 15 cases revealed only 1 with a pathogenic microorganism, Mycobacterium angelicum.Conclusion:In our experience, GPLB are heterogenous with only 3 cases having an identifiable infectious etiology and many of the remaining cases being associated to multiple medications, suggesting drug-induced liver injury as possible etiology.
pediatrics,pathology
What problem does this paper attempt to address?